Volume 49, May 2014 concentration were assessed for physical and chemical stability over a total period of 60 days. Stabilities were assessed on days 0, 7, 14, 21, 30, 45, and 60.
Physical Evaluation
Physical stability of phenylephrine was assessed by visual examination. Solutions were evaluated against a black and white background for visible particulate matter, cloudiness, or color change. The pH of the samples was not assessed, as previous studies have not demonstrated appreciable changes in pH. 3
High-Performance Liquid Chromatographic Analysis
Phenylephrine concentrations were determined by using high-performance liquid chromatography (HPLC) with ultraviolet detection according to previously published stability-indicating methods with minor modifi cations. 2, 3 The HPLC system utilized an autosampler c , delivery pump d , C-18 column e , a variable-wavelength ultraviolet light detector set at 273 nm f , a data integrator g , and a solvent waste container. The mobile phase consisted of 0.02 M ammonium acetate with 4% (v/v) acetonitrile adjusted with 1 N sodium hydroxide to a pH of 7.2 and was set to a fl ow rate of 1 mL/min. Analytical-grade phenylephrine h powder was used for validation and quality control of the HPLC assay. Aliquots of phenylephrine (20 μL) were then injected into the HPLC system for analysis.
Chromatogram peak heights were utilized for determining phenylephrine concentrations. All samples for each of the storage conditions were assayed in duplicate. Calibration of the HPLC system utilized 8 known concentrations from 100 to 450 μg/mL of phenylephrine and was conducted twice daily on each of the study days. The accuracy and precision of our assay met standards set for bioanalytical method validation. 4
Stability Analysis
The percentage of phenylephrine remaining at each time point was determined. The product was deemed stable if there was less than 10% degradation of the initial product.
RESULTS
Phenylephrine diluted to 200 and 400 μg/mL in 0.9% sodium chloride for injection was physically stable throughout the study. Less than 5% phenylephrine degradation was observed over the 60-day study period ( Table 1) . Solutions remained clear and no precipitation was observed throughout the study.
DISCUSSION
Previous studies have evaluated the extended stability of phenylephrine diluted in sodium chloride 0.9%. 2, 4 A study by Gupta 2 evaluated phenylephrine diluted to 100 and 200 mcg/mL in sodium chloride 0.9% PVC bags using stability-indicating HPLC analysis. This study found less than 1% degradation of phenylephrine when stored at room temperature exposed to light over a 14-day period. Kiser et al 4 utilized stability-indicating HPLC analysis to evaluate the stability of phenylephrine diluted to 100 mcg/mL in sodium chloride 0.9% packaged in polypropylene plastic syringes. Less than 2% degradation of phenylephrine was found over 30 days in syringes stored at room temperature exposed to light, refrigerated in the dark, or frozen in the dark. The present study similarly showed phenylephrine to be stable for at least 60 days when diluted to either 100 or 200 mcg/mL in sodium chloride 0.9% PVC bags and stored at room temperature exposed to light. Although phenylephrine was demonstrated to be stable for 60 days, the manufacturer does not Note: Preparations were exposed to normal fl uorescent lighting. Three polyvinyl chloride (PVC) bags were prepared for each concentration. Contents from each of these 6 admixtures were prepared and analyzed in duplicate for high-performance liquid chromatography (HPLC) analysis on the day of assay.
package phenylephrine vials with a preservative, and the sterility of prepared phenylephrine solutions must be assessed according to the standards in chapter 797 of the United States Pharmacopeia. 5 Our institution has utilized this information to implement batching phenylephrine in clinical practice. Twenty-one batches totaling 1,370 admixtures have been prepared and tested for sterility to date, with 100% of batches found to be sterile. Knowledge of the extended stability of phenylephrine in PVC bags will allow pharmacies to prepare infusions in advance and store them in automated medication dispensing machines on nursing units. This will allow immediate access to the medication and reduce drug delivery time, which is critically important for vasoactive medications. Additionally, extended stability is likely to reduce drug wastage over time.
CONCLUSION
Phenylephrine diluted to 100 and 200 mcg/mL in sodium chloride 0.9% injection was stable for at least 60 days when stored in PVC bags at room temperature.
